Aimei Health Technology Co., Ltd.

Aimei Health Technology Co., Ltd., trading under the ticker AFJK on Nasdaq, is the combined company formed through the de-SPAC merger of AF Acquisition Corp, a blank check company that completed its business combination with the China-based health technology firm. AF Acquisition Corp launched its IPO in 2022, targeting the healthcare and health technology sector with a focus on Asia-Pacific opportunities. The company filed an 8-K current report with the SEC on December 2, 2025, reflecting its status as an active post-merger reporting entity in the health technology space. For complete filing history, sponsor details, and real-time SPAC analytics on AFJK, sign up for full data access at SpacDesk.